COVID-19 vaccine: Zydus Cadila gets DGCI nod for phase 3 clinical trials of Pegylated Interferon Alpha-2
Drug firm Zydus Cadila on Friday said it has received the approval from the Drugs Controller General of India (DCGI) to start phase 3 clinical trials with its biological therapy PegiHep in COVID-19 pa
Read More